![Andrew Harbottle](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Andrew Harbottle
Directeur Technique/Scientifique/R&D chez MDNA Life Sciences, Inc.
Profil
Andrew Harbottle is currently the Chief Science Officer at MDNA Life Sciences, Inc. He obtained a doctorate degree from Newcastle University.
Postes actifs de Andrew Harbottle
Sociétés | Poste | Début |
---|---|---|
MDNA Life Sciences, Inc.
![]() MDNA Life Sciences, Inc. Medical/Nursing ServicesHealth Services MDNA Life Sciences, Inc. engages in the development of molecular tests based on the mitochondrial genome. It focuses on the development and commercial application of mitochondrial DNA based biomarkers for the early detection of prostate, ovarian and lung cancers, and endometriosis. The company was founded by Mark Birch-Machin, Robert Thayer, and Ryan L. Parr in 2001 and is headquartered in West Palm Beach, FL. | Directeur Technique/Scientifique/R&D | 01/11/2014 |
Formation de Andrew Harbottle
Newcastle University | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Entreprise privées | 1 |
---|---|
MDNA Life Sciences, Inc.
![]() MDNA Life Sciences, Inc. Medical/Nursing ServicesHealth Services MDNA Life Sciences, Inc. engages in the development of molecular tests based on the mitochondrial genome. It focuses on the development and commercial application of mitochondrial DNA based biomarkers for the early detection of prostate, ovarian and lung cancers, and endometriosis. The company was founded by Mark Birch-Machin, Robert Thayer, and Ryan L. Parr in 2001 and is headquartered in West Palm Beach, FL. | Health Services |